Double blind placebo controlled study for the role of budesonide in meconium aspiration syndrome

Role of budesonide nebulisation in neonates with meconium aspiration syndrome

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019947

Enrollment

Registered

2019-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J708- Respiratory conditions due to other specified external agents

Interventions

Intervention1: budesonide nebulisation: 2ml respule budesonide nebulisation in meconium aspiration syndrome of new borns at admission and after 12hours Control Intervention1: normal saline: nebulisati

Eligibility

Inclusion criteria

Inclusion criteria: new born

Exclusion criteria

Exclusion criteria: sepsis

Design outcomes

Primary

Measure	Time frame
downes scoreTimepoint: 72 hrs	—

Secondary

Measure	Time frame
hospital durationTimepoint: 72 hours	—

Countries

India

Contacts

Public ContactDr Amita tyagi

SDN hospital

dramitatyagi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026